Intercytex(英国)

Intercytex

英国Intercytex www.intercytex.comIntercytex市值约为1,050万英镑，该公司目前正在研发一种男性抗脱发药物。Intercytexistheleadingdeveloperofinnovativeregenerativemedicineproducts.Intercytexusesitsfullyintegratedcelltechnologyplatformt odevelopliving,humancell-basedproducts,atcommerciallyviablescaleinattractivemarkets.Intercytexhasfourproductsindevelopment: VAVELTA®,askinrepairandrejuvenationproductintendedtoimprovethefeel,functionandappearanceofskindamagedbyscarringandtheagingprocess,commerciallyavailablefromanumberofaccreditedcentresintheUKSHEF-1,developmentofastemcelllinesuitablefordifferentiationintoretinalpigmentepithelial(RPE)cells,beingcarriedoutincollaborationwiththeLondonProjecttoCureBlindnessICX-SKN,beingdevelopedasaskingraftreplacementforburnsandacutewounds,PhaseItrialscompletedICX-TR